Evidence map›Paper›PMID 38796067›Full record

ArticleThe Journal of biological chemistry2024

An upstream enhancer and MEF2 transcription factors fine-tune the regulation of the Bdnf gene in cortical and hippocampal neurons.

Annela Avarlaid, Kaisa Falkenberg, Karin Lehe, Giuseppa Mudò, Natale Belluardo, Valentina Di Liberto, Monica Frinchi, Jürgen Tuvikene, Tõnis Timmusk

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. The function ofFrontiers in cellular neuroscience · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Annela AvarlaidDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia. Electronic address: annela.avarlaid@taltech.ee.
Kaisa FalkenbergDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.
Karin LeheDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.
Giuseppa MudòDepartment of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy.
Natale BelluardoDepartment of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy.
Valentina Di LibertoDepartment of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy.
Monica FrinchiDepartment of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, Palermo, Italy.
Jürgen TuvikeneDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia; Protobios LLC, Tallinn, Estonia.
Tõnis TimmuskDepartment of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia; Protobios LLC, Tallinn, Estonia. Electronic address: tonis.timmusk@taltech.ee.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The myocyte enhancer factor (MEF2) family of transcription factors, originally discovered for its pivotal role in muscle development and function, has emerged as an essential regulator in various aspects of brain development and neuronal plasticity. The MEF2 transcription factors are known to regulate numerous important genes in the nervous system, including brain-derived neurotrophic factor (BDNF), a small secreted neurotrophin responsible for promoting the survival, growth, and differentiation of neurons. The expression of the Bdnf gene is spatiotemporally controlled by various transcription factors binding to both its proximal and distal regulatory regions. While previous studies have investigated the connection between MEF2 transcription factors and Bdnf, the endogenous function of MEF2 factors in the transcriptional regulation of Bdnf remains largely unknown. Here, we aimed to deepen the knowledge of MEF2 transcription factors and their role in the regulation of Bdnf comparatively in rat cortical and hippocampal neurons. As a result, we demonstrate that the MEF2 transcription factor-dependent enhancer located at -4.8 kb from the Bdnf gene regulates the endogenous expression of Bdnf in hippocampal neurons. In addition, we confirm neuronal activity-dependent activation of the -4.8 kb enhancer in vivo. Finally, we show that specific MEF2 family transcription factors have unique roles in the regulation of Bdnf, with the specific function varying based on the particular brain region and stimuli. Altogether, we present MEF2 family transcription factors as crucial regulators of Bdnf expression, fine-tuning Bdnf expression through both distal and proximal regulatory regions.

Indexed as

Brain-Derived Neurotrophic FactorEnhancer Elements, GeneticHippocampusMEF2 Transcription FactorsNeuronsAnimalsCells, CulturedCerebral CortexGene Expression RegulationRatsRats, Sprague-DawleyBdnf protein, ratBrain-Derived Neurotrophic FactorMEF2 Transcription FactorsBDNFbrain-derived neurotrophic factorcortexenhancerhippocampusMEF2myocyte enhancer factor 2transcriptional regulation

Identifiers

PMID38796067
PMCPMC11234010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.